Two Sigma Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $699K | Sell |
|
|||||
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $1.26M | Sell |
|
|||||
|
2024
Q4 | $2.08M | Sell |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.65M | Sell |
|
|||||
|
2023
Q4 | $1.54M | Buy |
|
|||||
|
2023
Q3 | $177K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $683K | Buy |
|
|||||
|
2022
Q4 | $169K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $190K | Sell |
|
|||||
|
2021
Q3 | $1.98M | Sell |
|
|||||
|
2021
Q2 | $6.59M | Buy |
|
|||||
|
2021
Q1 | $4.39M | Buy |
|
|||||
|
2020
Q4 | $557K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $157K | Sell |
|
|||||
|
2019
Q1 | $981K | Buy |
|
|||||
|
2018
Q4 | $778K | Buy |
|